Previous studies have demonstrated single nucleotide polymorphisms in FOXO3 in peripheral blood of asthma patients [19, 50], and the expression of FOXO3 decreased significantly in the lungs of smokers or COPD patients [14]. Here, FOXO3 is linked to chronic obstructive pulmonary disease.